Park Medi World Ltd (PARKHOSPS) is currently trading at 287.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Park Medi World Limited operates one of the largest private hospital chains in North India, offering over 30 medical specialties and cutting-edge healthcare services across 14 NABH-accredited hospitals. In 2025, they reported robust financial performance, including a 17% revenue increase, signifying effective growth strategy execution and solid operational capabilities. Recent strategic acquisitions in New Delhi and Agra mark significant milestones in their expansion, aiming to integrate these facilities into their existing network effectively. Plans to increase their hospital bed count from the current 3,250 to 5,260 by 2028 demonstrate a strong commitment to cater to healthcare demands in underserved urban areas efficiently. Focus on operational and technological enhancements, including robotic-assisted surgeries, underscores their intent to remain at the forefront of healthcare innovation while maintaining cost-efficiency.

Over the past 52 weeks, Park Medi World Ltd has traded between a low of ₹138.15 and a high of ₹305.25. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Park Medi World Ltd has a market capitalization of approximately 12,424.49. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Park Medi World Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 48.99 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 12,424.49 Cr, Park Medi World Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Park Medi World Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Park Medi World Ltd is 48.99. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The stock gained as the company updated exchanges about the schedule for approving Q1FY27 unaudited results and confirmed an analyst and institutional investor call on August 4, 2026.

Park Medi World reported consolidated net profit after tax of ₹825.00 million for the quarter, compared with ₹579.00 million in the corresponding quarter last year.

The company disclosed an all-cash deal of about ₹1,770 million to acquire a 100% stake in the 330-bed hospital.

Revenue from operations was reported at Rs 460.4 crore and consolidated net profit at Rs 71 crore, versus Rs 354 crore revenue and Rs 45 crore profit a year earlier.